Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Manfro

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
AMB : Revista Da Associacao Medica Brasileira|October 1, 1991
[Cyclosporin A: drug interactions]E Barros, R C Manfro, A Saick, et al.
Transplantation Proceedings|May 16, 2002
Protocol biopsies in renal transplant patients: three-years' follow-upF V Veronese, I L Noronha, R C Manfro, et al.
Revista Da Associacao Medica Brasileira (1992)|July 22, 1999
[Percutaneous renal allograft biopsy: where are we going?]F V Veronese, A D Centeno, A G de Almeida, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 27, 2005
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patientsM M Nascimento, A Bruchfeld, M E Suliman, et al.
Kidney International|January 25, 2008
Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft functionE C Aquino-Dias, G Joelsons, D M da Silva, et al.
Transplantation Proceedings|May 6, 2008
Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantationR Toresan, R C Manfro, M C C Proença, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneysJ O Medina Pestana, J M Grinyo, Y Vanrenterghem, et al.
Transplantation Proceedings|July 13, 2010
Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimusH Tedesco-Silva, V Duro Garcia, F L C Contieri, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 10, 2016
Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experienceA R Vicari, F Spuldaro, T V Sandes-Freitas, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
AMB : Revista Da Associacao Medica Brasileira|October 1, 1991
[Cyclosporin A: drug interactions]E Barros, R C Manfro, A Saick, et al.
Transplantation Proceedings|May 16, 2002
Protocol biopsies in renal transplant patients: three-years' follow-upF V Veronese, I L Noronha, R C Manfro, et al.
Revista Da Associacao Medica Brasileira (1992)|July 22, 1999
[Percutaneous renal allograft biopsy: where are we going?]F V Veronese, A D Centeno, A G de Almeida, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 27, 2005
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patientsM M Nascimento, A Bruchfeld, M E Suliman, et al.
Kidney International|January 25, 2008
Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft functionE C Aquino-Dias, G Joelsons, D M da Silva, et al.
Transplantation Proceedings|May 6, 2008
Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantationR Toresan, R C Manfro, M C C Proença, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2012
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneysJ O Medina Pestana, J M Grinyo, Y Vanrenterghem, et al.
Transplantation Proceedings|July 13, 2010
Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimusH Tedesco-Silva, V Duro Garcia, F L C Contieri, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 10, 2016
Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experienceA R Vicari, F Spuldaro, T V Sandes-Freitas, et al.
Pageof 6